HIV/AIDS Clinical Trial
— TWCOfficial title:
A Randomized Controlled Trial of Trans Women Connected: a Mobile App Delivered Sexual Health Promotion Program
Verified date | December 2023 |
Source | ETR Associates |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
Status | Completed |
Enrollment | 574 |
Est. completion date | September 7, 2022 |
Est. primary completion date | September 7, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 49 Years |
Eligibility | Inclusion Criteria: 1. aged 18-49 at the start of the study. 2. self-identify as transgender women 3. self-identify as sexually active with more than one partner in the prior 90 days 4. at least one sexual partner in the last 90 days had a penis 5. has a smartphone 6. resides in the U.S. Exclusion Criteria: Anyone not meeting inclusion criteria |
Country | Name | City | State |
---|---|---|---|
United States | ETR | Scotts Valley | California |
Lead Sponsor | Collaborator |
---|---|
ETR Associates | dfusion Inc, National Institute on Minority Health and Health Disparities (NIMHD), Portland State University |
United States,
Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005 Dec;9(4):387-402. doi: 10.1007/s10461-005-9012-3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | 3-months post intervention | |
Primary | Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | 6-months post intervention | |
Primary | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | 3-months post intervention | |
Primary | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | 6-months post intervention | |
Secondary | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse | 3-month post intervention | |
Secondary | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse | 6-month post intervention | |
Secondary | Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | 3-months post intervention | |
Secondary | Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | 6-months post intervention | |
Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 1-month post intervention | |
Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 3-month post intervention | |
Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 6-month post intervention | |
Secondary | Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support | 3-months post intervention | |
Secondary | Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support | 6-months post intervention | |
Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 1-month post intervention | |
Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 3-month post intervention | |
Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 6-month post intervention | |
Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 1 month post-intervention | |
Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 3- month post intervention | |
Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 6-month post intervention | |
Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 1-month post intervention | |
Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 3-month post intervention | |
Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 6- month post intervention | |
Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 1-month post intervention | |
Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 3-month post intervention | |
Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 6-month post intervention | |
Secondary | Trans Women Connected Satisfaction Survey | Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app. | 1-month post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|